SUMMARY Long-term complications of pterygium excision and beta irradiation in 63 eyes of 57 patients are described. 
Pterygium excision is a common ophthalmic operation that is often considered trivial, but without conjunctival radiotherapy recurrence rates may be as high as 69%, especially in the hot, dry, sunny environments of Australia1 and the Middle East.2
Numerous surgical modifications to simple excision have been reported, but none are notably advantageous.2 Beta irradiation after excision reduced the recurrence rate to a range of 05 %3 to 16%.1 Apart from local steroids, artificial tears, and dark glasses postoperatively, the only alternative treatment is topical thiotepa. Although reported to be as effective as radiotherapy,4 thiotepa has not been widely accepted.
Pterygium recurrence rates have often been reported, but late complications of pterygium treatment have received little emphasis. Fifty-seven patients with late complications are presented and their relationship to beta irradiation discussed.
Patients and methods
Patients with conjunctival, corneal, or scleral complications from previous pterygium treatment were obtained on request from other ophthalmologists and by a search of the records of 3 teaching hospitals. Four new cases presented at hospital clinics during the study. All but 5 patients were examined by one of us (K.H.T.). Adequate records and photographs for inclusion in parts of the study were available on these 5. Details of pterygium treatment, the course of ocular symptomatology, corrected visual acuities (VA), biomicroscopic measurement of avascular conjunctival patches, size of scleral ulceration and distance from the limbus, the position and assessment of ulcer depth, colour, and presence of overlying tissue were recorded. In addition telangiectatic vessels were noted, and after pupillary dilatation lens opacities were drawn and graded. The tear meniscus, break-up time, and results of an unstimulated Schirmer's test were recorded together with fluorescein and rose Bengal staining. Any other ocular pathology was noted and an external photograph was taken. Radiotherapy records with complete details of treatment were available in all but 2 patients. Of the 57 patients examined, 46 (51 eyes) had scleral ulceration, 2 had corneal ulceration, and 9 (10 eyes) had pathology confined mainly to the conjunctiva. The age of initial pterygium treatment with excision and beta irradiation ranged from 27 to 69 (mean 48 ±(SD) 11). Examination took place 3 to 20 years later (mean 12±3). There were 32 males and 25 females, of whom 1 was aboriginal and the rest were European.
Pterygium excision leaving bare sclera was used in all patients. In 15 eyes recurrent pterygia had been re-excised, and 8 of these had previously had beta irradiation (Table 1) . Beta irradiation was repeated in 5 eyes and involved overlapping fields in 2 other 496 Reduced vision was a major complaint in 6 patients (10%) ( Table 4) . Four patients (7%) presented with an acute red eye of which two had pseudomonas endophthalmitis.
SCLERAL ULCERATION
Scleral ulceration occurred in 51 eyes of 46 patients. Five patients had bilateral ulceration and 1 had a nasal and a temporal ulcer on the one eye. Clinically ulceration was classified into 3 grades. Superficial ulceration was characterised by exposed sclera with an irregular white surface and shallow ulceration less than one-third scleral thickness (6 eyes) ( Fig.  1 ). Moderate ulceration was characterised by a depth of one-third to two-thirds scleral thickness and a white base (14 eyes) (Fig. 2) . Deep ulceration was characterised by a depth of two-thirds or greater with a dark base (31 eyes with 32 ulcers) ( Fig. 3 ). Often only a thin layer of scleral fibres covered uveal tissue. In all 3 groups frequency and severity of symptoms were similar. There was no significant difference between the groups with respect to age at treatment (P<0-1), follow-up time (P<0 3), or total irradiation dosage when retreated cases were excluded (P<0-2) ( Table 5 ). The typical ulcer was 2-3 mm in diameter, had a corneal edge 1-2 mm from the limbus and was centred within half a clock hour of the horizontal meridian (Fig. 3 ). The ulcer usually had steep edges surrounded by very white avascular sclera, which was usually bare, and avascular conjunctiva with telangiectasia. The area of ulceration varied from 2 5 mm2 to 16 mm2 (mean 6-2±3-7 mm2). There was no correlation between area and ulcer depth ( Table  5 ). The centre of ulceration was more than 1 clock hour from the horizontal meridian in 9 eyes (17%).
Seven (13%) were inferiorly situated (Figs. 2 and 4).
It was often difficult to ascertain whether the sclera was completely bare of any tissue. A thin transparent layer of tissue was present in 11 eyes (21%) on careful biomicroscopy with cobalt blue light. Four (7%) had a documented history of persistent bare sciera with punctate rose Bengal staining and failure of conjunctival regrowth after initial treatment for 1 to 7 years before ulceration developed. In 3 eyes a row of 2-4 translucent small spots were present. These were separate spots equidistant from the limbus by 1-5 to 2 mm, in line with the scleral ulcer. From 2 of these a small (0 5 mm) vascular tuft arose. This was not connected to surrounding surface vessels. Similar tufts were seen within the bare area unassociated with translucent spots in a few other eyes. A small encrustation occurred on the adjacent conjunctiva or in the ulcer bed in 10 eyes (20%). This was rough, hard, and stained with fluorescein and rose Bengal. An analysis revealed calcium and other crystals which were birefringent negative to a red plate compensator, suggesting urate. Episcleral vessels partially covered the ulcer base in 13 eyes (25%). In 4 eyes previous photographs revealed minimal vessel extension over 2 to 6 years. Telangiectasia surrounded the bare sclera in 48 eyes (92%) and was severe and cosmetically unacceptable in 18 (34%).
Two scleral ulcers were atypical. One was a small 1-5 mm diameter punched-out moderately deep ulcer covered by mildly abnormal conjunctiva. It developed 10 years after excision and a single dose of 750 rads. The other was a vertical curvilinear full-thickness scleral defect with a knuckle of uveal tissue covered by avascular and telangiectatic conjunctiva (Fig. 5) . It was noted on routine examination 12 years after repeated excision and beta irradiation. Both eyes were treated, initially with 4000 rads over 2 weeks, then 10 months later a further 2400 rads was given to 2 overlapping fields. The scleral slit was perpendicular to the axis of the overlap. The fellow eye had white avascular sclera covered by avascular conjunctiva with surrounding telangiectatic vessels.
SURFACE PATHOLOGY IN EYES WITHOUT ULCERATION
Ten eyes of 9 patients had no ulceration and pathology mainly confined to the conjunctiva. This group did not significantly differ from those with Late complications ofpterygium treatment ulceration with respect to age (P<0 1), follow-up (P<0 1), or total dose of beta irradiation (P<0-2) (Table 5 ). When analysed in combination with the superficial scleral group, the lesser affected patients were significantly younger than patients with deeper ulceration (P<0-01). Conjunctival pathology consisted of severe telangiectasia in 6 eyes (60%) and thinned avascular conjunctiva of area 3 to 18 mm (mean 9 mm) with an adherent encrustation in 3 (30%). Three (30%) had recurrent pterygia. The underlying sclera had a very white appearance in 8 (80%).
FELLOW EYES
Thirteen patients with unilateral ulceration had fellow eyes with previous pterygium excision and beta irradiation (Table 1) . None were symptomatic. Four had recurrent pterygia present, to make a total of 12 eyes (16%) with recurrent pterygia after excision and beta irradiation. The conjunctiva was mildly abnormal in 6 fellow eyes (46%). Thirtyeight fellow eyes had no previous beta irradiation.
Six eyes (16%) had untreated pterygia. One of 5 pterygia previously treated by simple excision alone had recurred.
CORNEAL ULCERATION
Indolent corneal ulcers occurred in 2 patients. One was aged 34 years at the time of initial unilateral pterygium treatment with simple excision and beta irradiation with 5000 rads in 3 doses over 2 weeks. An elliptical strontium applicator, active area of 13x 18 mm and emission rate of 14 8 rads s-1, was used. The eye was persistently sore and irritable after treatment until 10 years later, when a diagnosis of corneal ulceration was made (Fig. 6) .
The ulceration of half corneal thickness was vertically oval and measured 2x 3 mm. The edge was 1 mm from the limbus and situated at the site of the previous pterygium head. The ulcer edge and base were irregular, and the bulbar conjunctiva had a large avascular patch surrounded by prominent telangiectatic vessels. The tear film was normal and there was no corneal staining elsewhere.
The other patient who developed corneal ulceration was aged 36 years at the time of treatment 12 years before examination. Bilateral pterygia were excised and beta irradiation with 3600 rads in 3 doses over 2 weeks given.
A (Fig. 7) . The anterior cortex was involved in more severe cataracts. Thirteen eyes (25%) with scleral ulceration and I with corneal ulceration had such opacities. No equivalent opacities were seen in these eyes on the temporal side or in untreated fellow eyes. Three untreated eyes had diffuse equatorial or posterior polar cataracts. There was no significant difference in age (P<0-1 5) between patients with and without sectorial opacities, but those with opacities had been followed up significantly longer (P<0.01). The total dose of beta irradiation was significantly greater (P<0-00l) for eyes with sectorial opacities and normal vision than for those without opacities ( Peripheral corneal infiltration and a large hypopyon were present together with a mucopurulent discharge (Fig. 8) (Table 2) . Apart from these 3 irradiation dosage ranged from 750 to 5200 rads (mean 3386±1079). The remaining 12 patients had unilateral scleral ulceration despite bilateral pterygium treatment. Nine patients had similar treatment given to each eye. Eight had a single course of beta irradiation (range 2400 to 4800 rads, mean 3437± 944). One ulcer was superficial, 1 moderately deep, and 6 deep. One patient had bilateral repeated beta irradiation with unilateral atypical ulceration (Table 2, no. 5). Three patients developed ulceration only in the eye given additional beta irradiation (Table 2) . Apart from retreated and overlapping fields of beta irradiation 1 eye had a single dose of 750 rads and the remainder had fractionated treatment (Table 3) with a total dose of 2000 to 2400 rads in 10 eyes, 2500 to 3400 in 9 eyes, 3500 to 4400 in 25 eyes, and 4500 to 5200 in 7 eyes. Six patients with ulceration were initially treated before 1964 , 12 during 1964 -6, 22 during 1967 -9, 5 during 1970 -2, and I in 1974 Cosmesis, irritation, or threatened vision are standard indications for pterygium treatment, yet most do not cause marked discomfort or limit vision.1 6 Reduced visual acuity from untreated pterygia was present in only 0-2% of 1352 patients7 in one series and other reports are of single cases.' 8 The efficacy of pterygium treatment is limited by a high recurrence rate without beta irradiation'7 and other complications. Apart from recurrence rates, late complications have received little attention.
Patient acceptance of treatment and subsequent ocular discomfort should be important considerations in pterygium treatment. Treatment was a painful experience in 32% of the population we studied, and this was universally attributed to beta irradiation. Pain may arise from repeated mechanical damage during application or from acute punctate corneal erosion.9 Ocular discomfort and photophobia persisted for many years in 42% of our subjects despite protective measures and topical treatment. The severity of symptoms did not correlate with the size or depth of scleral ulceration.
Scleral ulceration after pterygium excision and beta irradiation has been previously reported.10- '6 In our 46 patients with 52 scleral ulcers the depth of ulceration did not correlate with patient age at treatment, follow-up time, or total dose of radiation. The ulcer was inferiorly situated in 7 eyes (13%). This would be consistent with elevation of the eye during radiation treatment if ulceration occurs at the point of contact of the applicator on the eye. The nature and timing of ulceration, the appearance of the sclera and adjacent tissues, and the development of ulceration only after additional beta irradiation clearly implicate radiation induced pathology in the pathogenesis of scleral ulceration. However, sclera is generally known to be radioresistant. Very high doses of beta irradiation to rabbit eyes have produced no scleral ulceration. '6 In man beta irradiation to the posterior sclera with up to 100 000 rads over 8-14 days did not cause necrosis in 62 patients followed up for 1 to 9 years (mean 4 years).'7 Reports of 'partial scleral sloughing"8 and scleral necrosis'920 following very high doses of cobalt-60 plaque treatment do exist but are rare. At least 1 such case occurred anteriorly in association with the conjunctiva.'9 On the other hand high doses of radiation are not necessary for scleral ulceration to develop anteriorly.'6 Even with the currently used dose of 2400 rads or less, 11 scleral ulcers were seen in our series. It would appear that an additional factor contributes to 'radionecrosis' of the sclera anteriorly. Possible factors include surgical damage, scleral exposure, the influence of damaged conjunctiva, or the tears.
Faulty surgical technique, particularly cautery, has been implicated.610'2 An irregular distribution of translucent spots within the bare sclera followed the use of a heavy tipped cautery in 1 reported case.12 In our survey 3 eyes had translucent spots, but in an area equidistant from the limbus. A small vascular tuft arose from some spots. The appearance suggested that these spots developed at the penetration site of anterior ciliary vessels. The location would be more random if due to surgical damage. The appearance of I atypical case (Table 2, no. 5) did suggest a scleral incision.
The possible role of exposure has been the subject of a short-term experimental study in rabbits by the authors (to be published). It has been found that exposure alone may cause rapid and indolent scleral necrosis. Bare sclera persisting after pterygium treatment has been previously noted and may occur without symptoms in many patients."101213 Four of our patients (61%) were noted to have persistent bare sclera for 1 to 7 years before developing ulceration. In eyes that do regain conjunctival cover late conjunctival necrosis could precede scleral ulceration. The presence of bare sclera in almost all ulcerated eyes and the occurrence of ulceration after low doses of radiation suggests that conjunctival breakdown is the first event.
In this survey ulcerated eyes had a slightly greater tear production than nonulcerated fellow eyes (P<005). Therefore it is felt that lack of tears is not a significant factor.
Pseudomonas Beta irradiation-induced cataract is well documented. In one series 38 of 115 patients had nonprogressive lens opacities when examined a minimum of 8 years after beta irradiation.22 20% of patients who received less than 3600 reps developed opacities (1 rep= 1-08 rads tissue). Hilgers23 found no lens opacities 5 years after a fractionated dose of 3000 reps of strontium-90 beta irradiation, but 3 of 46 eyes (6%) developed lens opacities after 3000-5000 reps. This incidence was considered acceptable to maintain a low rate of pterygium recurrence. In addition a single dose of 2200 rads after pterygium excision has been considered safe even when repeated twice for subsequent recurrences.' Typical sectorial posterior cortical lens opacities, with a visual acuity of 6/9 or better, were present in 19 eyes (25%) in this survey. The total dose of beta irradiation ranged from 2900 to 5200 rads (Table 6 ). The anterior cortex was involved only in the more severe cataracts, an observation previously noted.24 Compared to patients without cataract our patients showed no significant difference in age or length of follow-up, but a strong correlation was found with respect to the total dose of radiation (P<0 001). This survey confirms that some opacities will develop after a fractionated dose of 3000-5000 rads.
Reduced vision from beta irradiation-induced cataract is not common. Seven cases occurred 3 to 6-5 years after radium beta irradiation.25 None has been reported after pterygium excision and strontium-90 beta irradiation. In this study radiationinduced cataract caused reduced vision in 3 patients. (Table 4 , nos. 1, 2, 3). The influence of beta irradiation on cataract formation in the other 6 patients in Table 4 cannot be determined. The fact that these patients were older at treatment than those with normal vision (P<0 001) probably reflects the distribution of senile cataract rather than any susceptibility of the older lens to radiation. It is the younger growing lens that is particularly susceptible.
This survey would support a more cautious attitude both to the management of pterygium and to the use of beta irradiation. The complications of treatment, especially scleral necrosis and cataract, may lead to visual loss. With scleral ulceration, surgical treatment may be indicated to relieve symptoms alone and should certainly be considered for deep scleral ulceration to prevent pseudomonas endophthalmitis. The development of cataract after treatment of a benign lesion is not acceptable. There is a need to reconsider the indications for surgical treatment and the application of beta irradiation. Lower doses of radiation may reduce the complication rate but may also be less effective in preventing recurrence.
